Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Constantine S Mitsiades, M.D., Ph.D.

Concepts (553)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Constantine Mitsiades's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Constantine Mitsiades has written about over time.
NF-kappa B, 11 publications between 2001 and 2024, average publication date July 2008. Thalidomide, 27 publications between 2002 and 2015, average publication date March 2009. Pyrazines, 31 publications between 2002 and 2015, average publication date July 2009. Tumor Cells, Cultured, 19 publications between 2001 and 2021, average publication date July 2009. Apoptosis, 31 publications between 2001 and 2023, average publication date January 2010. Boronic Acids, 33 publications between 2002 and 2021, average publication date January 2010. Antineoplastic Agents, 56 publications between 2002 and 2023, average publication date February 2011. Multiple Myeloma, 108 publications between 2001 and 2024, average publication date March 2011. Drug Resistance, Neoplasm, 24 publications between 2001 and 2023, average publication date June 2011. Drug Screening Assays, Antitumor, 9 publications between 2009 and 2014, average publication date July 2011. Stromal Cells, 14 publications between 2007 and 2019, average publication date October 2011. Proteasome Endopeptidase Complex, 9 publications between 2002 and 2021, average publication date April 2013. Cell Line, Tumor, 39 publications between 2003 and 2023, average publication date June 2014. Gene Expression Regulation, Neoplastic, 17 publications between 2003 and 2021, average publication date August 2014. Xenograft Model Antitumor Assays, 15 publications between 2008 and 2021, average publication date December 2014. Proto-Oncogene Proteins c-myc, 3 publications between 2011 and 2021, average publication date November 2017. Cytotoxicity, Immunologic, 4 publications between 2013 and 2023, average publication date January 2018. Von Hippel-Lindau Tumor Suppressor Protein, 1 publications between 2021 and 2021, average publication date January 2021.

To see the data from this visualization as text, click here.
Mitsiades's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (553)
Explore
_
Co-Authors (114)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.